Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BRUCE ALLEN PENDLEY

Allopathic & Osteopathic Physicians Family Medicine

NPI
1881634483
CMS profile
130297
Location
EAST RIDGE, TN

General Payments · PY2018–2024

$4,709.69

  • Reported across 161 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$434.39

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $434.39 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $648.16 26
PY2019 $1,556.76 43
PY2020 $470.41 19
PY2021 $431.75 16
PY2022 $523.17 22
PY2023 $645.05 19
PY2024 $434.39 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ACADIA Pharmaceuticals Inc $20.03 03/07/2024 Food and Beverage Undisputed 01/23/2026 1147987282 CMS
AstraZeneca Pharmaceuticals LP $20.39 02/07/2024 Food and Beverage Undisputed 01/23/2026 1105528924 CMS
AstraZeneca Pharmaceuticals LP $22.87 06/07/2024 Food and Beverage Undisputed 01/23/2026 1104307422 CMS
AstraZeneca Pharmaceuticals LP $91.11 10/09/2024 Food and Beverage Undisputed 01/23/2026 1104731197 CMS
Eisai Inc. $14.81 02/09/2024 Food and Beverage Undisputed 01/23/2026 1110735033 CMS
Lilly USA, LLC $14.29 04/03/2024 Food and Beverage Undisputed 01/23/2026 1136080810 CMS
Neurocrine Biosciences, Inc. $24.88 04/04/2024 Food and Beverage Undisputed 01/23/2026 1150840250 CMS
Neurocrine Biosciences, Inc. $13.40 08/08/2024 Food and Beverage Undisputed 01/23/2026 1150878817 CMS
Neurocrine Biosciences, Inc. $22.29 12/05/2024 Food and Beverage Undisputed 01/23/2026 1150850276 CMS
Otsuka America Pharmaceutical, Inc. $21.44 04/09/2024 Food and Beverage Undisputed 01/23/2026 1118959897 CMS
Otsuka America Pharmaceutical, Inc. $19.83 10/18/2024 Food and Beverage Undisputed 01/23/2026 1118959899 CMS
Otsuka America Pharmaceutical, Inc. $20.92 11/20/2024 Food and Beverage Undisputed 01/23/2026 1118959901 CMS
SHIELD THERAPEUTICS INC $16.90 10/08/2024 Food and Beverage Undisputed 01/23/2026 1150148799 CMS
Teva Pharmaceuticals USA, Inc. $28.57 05/10/2024 Food and Beverage Undisputed 01/23/2026 1151753434 CMS
UCB, Inc. $42.35 07/12/2024 Food and Beverage Undisputed 01/23/2026 1143080364 CMS
UCB, Inc. $40.31 09/11/2024 Food and Beverage Undisputed 01/23/2026 1143080366 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.